Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D53KHJ
|
|||
| Drug Name |
mRNA-1045
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza [ICD-11: 1E30-1E32; ICD-10: J10, J11; ICD-9: 487, 488] | Phase 1 | [1] | |
| Respiratory syncytial virus infection [ICD-11: 1C80; ICD-9: 79.6] | Phase 1 | [1] | ||
| Company |
Moderna
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05585632) Phase 1, Randomized, Observer-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Multi-component Vaccines mRNA-1045 (Influenza and RSV) or mRNA-1230 (Influenza, RSV, and SARS-CoV-2) Compared With mRNA-1010 (Influenza), mRNA-1345 (RSV), and mRNA-1273.214 (SARS-CoV-2) Vaccines in Healthy Adults 50-75 Years of Age. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.